Loading clinical trials...
Loading clinical trials...
A Randomised, Double-Blind, Placebo-Controlled, 3 x 3 Factorial Trial of Telmisartan and Hydrochlorothiazide in Patients With Essential Hypertension
Conditions
Interventions
Telmisartan
Hydrochlorothiazide
+1 more
Locations
24
Japan
Boehringer Ingelheim Investigational Site
Annaka, Gunma, Japan
Boehringer Ingelheim Investigational Site
Asahi,Chiba, Japan
Boehringer Ingelheim Investigational Site
Fukuoka, Fukuoka, Japan
Boehringer Ingelheim Investigational Site
Fukuoka, Fukuoka, Japan
Boehringer Ingelheim Investigational Site
Ichinomiya, Aichi, Japan
Boehringer Ingelheim Investigational Site
Iida,Nagano, Japan
Start Date
June 1, 2004
Primary Completion Date
June 1, 2005
Completion Date
June 1, 2005
Last Updated
November 8, 2013
NCT02417740
NCT07480265
NCT07073820
NCT06876233
NCT06062394
NCT06899815
Lead Sponsor
Boehringer Ingelheim
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions